The gold(III) methoxide complex (CNC)AuOMe () reacts with tris(-tolyl)phosphine in benzene at room temperature under O abstraction to give the methylgold product (CNC)AuMe () together with O=P(-tol) ((CNC) = [2,6-(CH Bu-4)pyridine]). Calculations show that this reaction is energetically favorable (Δ = -32.3 kcal mol). The side products in this reaction, the Au(II) complex [Au(CNC)] () and the phosphorane (-tol)P(OMe), suggest that at least two reaction pathways may operate, including one involving (CNC)Au radicals. Attempts to model the reaction by DFT methods showed that PPh can approach to give a near-linear Au-O-P arrangement, without phosphine coordination to gold. The analogous reaction of (CNC)AuOEt, on the other hand, gives exclusively a mixture of and (-tol)P(OEt). Whereas the reaction of (CNC)AuOR (R = Bu, -CHF) with P(-tol) proceeds over a period of hours, compounds with R = CHCF, CH(CF) react almost instantaneously, to give and O=P(-tol). In chlorinated solvents, treatment of the alkoxides (CNC)AuOR with phosphines generates [(CNC)Au(PR)]Cl, via Cl abstraction from the solvent. Attempts to extend the synthesis of gold(III) alkoxides to allyl alcohols were unsuccessful; the reaction of (CNC)AuOH with an excess of CH=CHCHOH in toluene led instead to allyl alcohol isomerization to give a mixture of gold alkyls, (CNC)AuR' (R' = -CHCHCHO (), -CHCH(CHOH)OCHCH=CH ()), while 2-methallyl alcohol affords R' = CHCH(Me)CHO (). The crystal structure of was determined. The formation of Au-C instead of the expected Au-O products is in line with the trend in metal-ligand bond dissociation energies for Au(III): M-H > M-C > M-O.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388904PMC
http://dx.doi.org/10.1021/acs.organomet.7b00077DOI Listing

Publication Analysis

Top Keywords

reaction
7
formation goldiii
4
goldiii alkyls
4
alkyls gold
4
gold alkoxide
4
alkoxide complexes
4
complexes goldiii
4
goldiii methoxide
4
methoxide complex
4
complex cncauome
4

Similar Publications

Erlotinib-induced Perioral Lesions Resembling Scleroderma.

Acta Dermatovenerol Croat

November 2024

Constantin A. Dasanu MD, PhD, Lucy Curci Cancer Center, Eisenhower Health, 39000 Bob Hope Dr, Rancho Mirage, CA 92270 , USA;

Erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), is currently used in the therapy of several solid malignancies. This agent has been associated with several dermatological side-effects, the most common being papulo-pustular acneiform rash. Herein we describe a unique skin effect in a patient treated with erlotinib for non-small cell lung cancer.

View Article and Find Full Text PDF

Phototoxic reaction to oral terbinafine due to Tinea capitis in a child.

Acta Dermatovenerol Croat

November 2024

Prof. Ana Bakija-Konsuo, MD, PhD, Clinic for Dermatovenerology CUTIS, Vukovarska 22, Dubrovnik, Croatia;

We report the case of an 18-month-old boy who developed a phototoxic skin reaction to terbinafine on his scalp, ears, and face in the form of disseminated erythematous plaques, which resembled subacute lupus erythematosus (SCLE) in their clinical presentation. Skin changes appeared a short time after the boy was exposed to sunlight during the period of time when he was treated with oral terbinafine due to Microsporum canis fungal scalp infection. Tinea capitis is a common dermatophyte infection primarily affecting prepubertal children (1).

View Article and Find Full Text PDF

Diagnosis, Investigation and Management of Non-immediate (Type IV) Cutaneous Adverse Drug Reactions.

Acta Dermatovenerol Croat

November 2024

Vesna Vukičević Lazarević, MD Special Hospital for Pulmonary Diseases, Rockefellerova 3, 10000 Zagreb, Croatia;

Pathophysiologically, drug hypersensitive reactions (DHRs) are classified into four types: type I, immediate reactions, and types II, III, and IV, non-immediate reactions. They are further categorized as severe or non-severe based on clinical severity. Genetic predisposition and viral reactivation are cofactors of severe DHR type IV.

View Article and Find Full Text PDF

Background: CT-P47 is a candidate tocilizumab biosimilar that is currently in clinical development. We assessed the usability of CT-P47 self-administration via auto-injector (AI) in patients with rheumatoid arthritis (RA).

Research Design And Methods: This was a 12-week, single-arm, open-label, multiple-dose, Phase 3 study.

View Article and Find Full Text PDF

IgE and cardiac disease.

Acta Physiol (Oxf)

February 2025

Department of Physiology, Pharmacology and Toxicology, West Virginia University, Morgantown, West Virginia, USA.

IgE acts primarily via the high affinity IgE receptor (FcεRI) and is central to immediate hypersensitivity reactions (anaphylaxis). However, IgE is also important in the development of chronic hypersensitivity reactions (allergy). In the cardiovascular system, numerous clinical studies have investigated serum IgE levels, mainly in the context of myocardial infarction, and have established a clear association between IgE and ischemic cardiac events.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!